Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
Stress can alter immunological, neurochemical and endocrinological functions, but its role in cancer progression is not well understood. Here, we show that chronic behavioral stress results in higher levels of tissue catecholamines, greater tumor burden and more invasive growth of ovarian carcinoma cells in an orthotopic mouse model. These effects are mediated primarily through activation of the tumor cell cyclic AMP (cAMP)-protein kinase A (PKA) signaling pathway by the beta(2) adrenergic receptor (encoded by ADRB2). Tumors in stressed animals showed markedly increased vascularization and enhanced expression of VEGF, MMP2 and MMP9, and we found that angiogenic processes mediated the effects of stress on tumor growth in vivo. These data identify beta-adrenergic activation of the cAMP-PKA signaling pathway as a major mechanism by which behavioral stress can enhance tumor angiogenesis in vivo and thereby promote malignant cell growth. These data also suggest that blocking ADRB-mediated angiogenesis could have therapeutic implications for the management of ovarian cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Parallel findings in animal and in vitro models support these data [11, 16–22].”
From Living Well: Protocol for a web-based program to improve quality of life in rural and urban ovarian cancer survivors (2024) · cites this paper as [16]
In the citing paper
“The tumor-promoting effect of catecholamines is mainly mediated by the β2 adrenergic receptor (encoded by ADRB2) activating the cAMP-protein kinase A (PKA) signaling pathway, which is the main mechanism to enhance tumor angiogenesis in the body and promote the growth of malignant cells [(34, 35); Figure 2].”
From Chronic Stress Promotes Cancer Development (2020) · cites this paper as [34]
In the citing paper
“Parallel effects have been observed in experimental animal models of cancer, and those analyses again identify a prominent role for SNS activation of β-adrenergic signaling [43], [44].”
From Human Social Genomics (2014) · cites this paper as [43]
Citations
Cites
Protective and Damaging Effects of Stress Mediators
McEwen, B. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801153380307 · Cited by 6,733
The Concepts of Stress and Stress System Disorders: Overview of Physical and Behavioral Homeostasis
Chrousos, G. P. (1992) · JAMA · doi:10.1001/jama.1992.03480090092034 · Cited by 2,689 · cited 1×
“Pharmacologic and genetic manipulations identify β-adrenergic signaling as a central mediator of stress effects in the model of stress used here, but these findings do not rule out the possibility that other neuroendocrine signaling pathways might modulate tumor cell biology under other circumstances (for example, str…”
BackgroundStress-induced immune dysfunction: implications for health
Glaser, R., & Kiecolt-Glaser, J. K. (2005) · Nature Reviews Immunology · doi:10.1038/nri1571 · Cited by 2,190 · cited 1×
“Previous research emphasized the role of the immune system in mediating stress effects on tumor growth and metastasi”
Stress, depression, the immune system, and cancer
Reiche, E. M. V., Nunes, S. O. V., & Morimoto, H. K. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01597-9 · Cited by 1,364
The influence of bio-behavioural factors on tumour biology: pathways and mechanisms
Antoni, M. H., Lutgendorf, S. K., Cole, S. W., Dhabhar, F. S., Sephton, S. E., McDonald, P. G., Stefanek, M., & Sood, A. K. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1820 · Cited by 981
Self-citationPassaniti, A., Taylor, R. M., Пили, Р., Guo, Y., Long, P., Haney, J. A., Pauly, R. R., Grant, D. S., & Martin, G. R. (1992) · PubMed · Cited by 806
Therapeutic EphA2 Gene Targeting In vivo Using Neutral Liposomal Small Interfering RNA Delivery
Landen, C. N., Chavez-Reyes, A., Bucana, C., Schmandt, R., Deavers, M. T., Lopez-Berestein, G., & Sood, A. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0530 · Cited by 675 · cited 1×
“To facilitate in vivo distribution, we incorporated the siRNA into a neutral liposome, DOP”
MethodSelf-citationBasu, S., Nagy, J. A., Pal, S., Vasile, E., Eckelhoefer, I. A., Susan Bliss, V., Manseau, E. J., Dasgupta, P. S., Dvorak, H. F., & Mukhopadhyay, D. (2001) · Nature Medicine · doi:10.1038/87895 · Cited by 396
Social support, psychological distress, and natural killer cell activity in ovarian cancer
Lutgendorf, S. K., Sood, A. K., Anderson, B., McGinn, S., Maiseri, H., Dao, M., Sorosky, J. I., De Geest, K., Ritchie, J., & Lubaroff, D. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.015 · Cited by 345 · cited 1×
“Previous research emphasized the role of the immune system in mediating stress effects on tumor growth and metastasi”
BackgroundSelf-citationLutgendorf, S. K., Cole, S. W., Costanzo, E. S., Bradley, S., Coffin, J. E., Jabbari, S., Rainwater, K. K., Ritchie, J. M., Yang, M., & Sood, A. K. (2003) · PubMed · Cited by 330
Self-citation
Research works printed but not linked: 1
- Halder, J. et al. Focal adhesion kinase targeting for therapy of ovarian carcinoma using in vivo siRNA delivery in neutral liposomes. Clin. Cancer Res. (in the press).
Cited by
Items 801–900 of 1,000
Mechanisms underlying the effects of stress on tumorigenesis and metastasis (Review)
Zhang, Z., Wang, Y., & Li, Q. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4570 · Cited by 17
“Studies have also revealed that inflammatory cells can be recruited by stress to tumor sites, increasing the formation of blood vessels (107).”
Kyritsi, K., Pacholczyk, R., Douglass, E. F., Yu, M., Fang, H., Zhou, G., Kaur, B., Wang, Q., Munn, D. H., & Hong, B. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-011322 · Cited by 12
Depressive Disorder Affects TME and Hormonal Changes Promoting Tumour Deterioration Development
Dong, J., Du, J., Liu, R., Gao, X., Wang, Y., Ma, L., Yang, Y., Wu, J. H., Yu, J., & Liu, N. (2025) · Immunology · doi:10.1111/imm.13933 · Cited by 12
“In animal models expressing β-AR cancer cell lines, stress exposure or β-AR stimulation increases tumour growth and/or metastasis through mechanisms such as tumour angiogenesis and increased TAM density [92, 93].”
A local sympathetic-immune axis inhibits melanoma growth in mice by dictating adrenergic control
Liu, T., Kutsovsky, D. Y., Earlie, E. M., Ji, L., Iskols, M., Ramsamooj, S., Dawkins, X. I., Zerhouni, M., Birbrair, A., Piskounova, E., et al. (2026) · Neuron · doi:10.1016/j.neuron.2026.04.016 · Cited by 14
Zhang, H., Han, J., Zhang, J., Miao, J., Li, F., Tang, K., Zhou, K., Duan, B., Li, W., Cheng, J., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01447-5 · Cited by 12
“The patients who participated in this work expressed informed consent.”
β2-AR inhibition enhances EGFR antibody efficacy hampering the oxidative stress response machinery
Vecchio, V. D., Mele, L. L., Panda, S. K., Sanchez-Pajares, I. R., Mosca, L., Tirino, V., Barbieri, M., Bruzzese, F., Luciano, A., Marino, F. Z., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06129-9 · Cited by 12
“The β 2-AR signaling promotes tumor initiation and progression by regulating several cell processes, such as apoptosis/anoikis [9, 10], autophagy, angiogenesis [11], in fl ammation and immune-response [12, 13], DNA damage, drug resistance and EMT [14, 15].”
Effect of acute inflammatory reaction induced by biopsy on tumor microenvironment
Chen, Y., Liu, H., & Sun, Y. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-05704-7 · Cited by 13
“Relevant studies (Al-Sahaf et al. 2010, Coffey et al. 2003, Demicheli et al. 2008, Ceelen et al. 2014, Thaker et al. 2006, Troester et al. 2009) have shown that surgical incisions, including biopsies, are associated with higher rates of local recurrence and elevated rates of lymph node metastasis.”
BackgroundBeta-blocker use and breast cancer outcomes: a meta-analysis
Scott, O. W., Tin, S. T., Cavadino, A., & Elwood, M. (2024) · Breast Cancer Research and Treatment · doi:10.1007/s10549-024-07263-4 · Cited by 16
Impact of kinase activating and inactivating patient mutations on binary PKA interactions
Röck, R., Mayrhofer, J. E., Bachmann, V., & Stefan, E. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00170 · Cited by 3
“Activation of different βAR subtypes are related to proliferation, cardiac function, and memory and learning (Daaka et al., 1997; Wong and Scott, 2004; Zhang et al., 2005; Thaker et al., 2006; Lefkowitz, 2007).”
Multitargeted Inhibitors in Lung Cancer: New Clinical Data
Bar, J., Herbst, R. S., & Onn, A. (2008) · Clinical Lung Cancer · doi:10.3816/clc.2008.s.014 · Cited by 12
Identify potential miRNA-mRNA regulatory networks contributing to high-risk neuroblastoma
Shao, F., Liu, Q., & Wang, S. (2021) · Investigational New Drugs · doi:10.1007/s10637-021-01064-y · Cited by 12
Beta-Elemene Reduces the Malignancy of Non-Small Cell Lung Cancer by Enhancing C3orf21 Expression
Cai, H., Ren, L., Wang, Y., & Zhang, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.571476 · Cited by 12
“Furthermore, VEGF is an important angiogenic factor and MMP2/9 are crucial for tumor cell motility (25).”
Backgroundzong, C., Yang, M., Guo, X., & Ji, W. (2022) · Oncology Letters · doi:10.3892/ol.2022.13420 · Cited by 16
“The ADRB2 signaling pathway has previously been reported to be activated under numerous stressful situa‐ tions (23,28,34,36,55).”
BackgroundAdding recombinant AAVs to the cancer therapeutics mix
Mulcrone, P. L., Herzog, R. W., & Xiao, W. (2022) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2022.09.009 · Cited by 13
The role of neurotransmitters in glioblastoma multiforme‐associated seizures
Joghataei, M. T., Bakhtiarzadeh, F., Dehghan, S., Ketabforoush, A. H. M. E., Golab, F., Zarbakhsh, S., & Ahmadirad, N. (2023) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10294 · Cited by 13
“Exposure to stress in any type of cancer increases the risk of tumor formation by activating the adrenergic system (Thaker et al., 2006).”
BackgroundZhang, L., Deng, Y., Yang, J., Deng, W., & Li, L. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1202193 · Cited by 13
“…has been shown to promote tumor growth and angiogenesis through increased expression of vascular endothelial growth factor, metalloproteases 2, and metalloproteases 9, which further enhance angiogenic and metastatic processes in ovarian, lung, and breast cancers (Thaker et al., 2006).”
BackgroundLe, C. P., & Sloan, E. K. (2016) · Molecular & Cellular Oncology · doi:10.1080/23723556.2016.1177674 · Cited by 15
“In particular, a growing body of evidence suggests that stressful events promote metastasis and lead to poor cancer survival,(2,3,5,6) although the routes of tumor cell dissemination are not clear.(2,5) Tumor cell invasion into the lymphatic system is linked to poor prognosis in solid tumors.”
BackgroundWen, Z.-Y., Gao, S., Gong, T., Jiang, Y., Zhang, J., Zhao, Y., & Wu, Q. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.665617 · Cited by 15
Vegas, Ó., Garmendia, L., Arregi, A., Beitia, G., & Azpiroz, A. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.06.033 · Cited by 13
Life stress, negative mood states, and antibodies to heat shock protein 70 in endometrial cancer
Pereira, D. B., Sannes, T. S., Dodd, S. M., Jensen, S. E., Morgan, L. S., & Chan, E. K. L. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.08.008 · Cited by 12
Jaeger, N., Czepielewski, R. S., Bagatini, M., Porto, B. N., & Bonorino, C. (2017) · Tumor Biology · doi:10.1177/1010428317694321 · Cited by 14
Xia, T., Li, S., Ma, R., Guan, S., Li, J., Li, H., Zhang, H., Qiu, L., Zhao, Z.-M., & Wang, B. (2017) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2017.04.005 · Cited by 11
Khashali, H. A., Darweesh, B., Ray, R., Haddad, B., Wozniak, C., Ranzenberger, R., Goel, S., Khalil, J., Guthrie, J. W., Heyl, D., et al. (2023) · Cancers · doi:10.3390/cancers15235500 · Cited by 13
“Increased secreted levels of VEGF were observed in a variety of cancer cells in response to β -AR signaling activation by adrenaline and noradrenaline, leading to increased tumor growth [26–28].”
BackgroundInfluentialCongenital Vascular and Lymphatic Diseases
Jung, R., & Trivedi, C. M. (2024) · Circulation Research · doi:10.1161/circresaha.124.323181 · Cited by 11
Blockhuys, S., & Wittung-Stafshede, P. E. (2024) · Complementary Medicine Research · doi:10.1159/000540213 · Cited by 12
“This resulted in enhanced tumor vascularization and aggressive growth and spread of malignant cells [10].”
Xu, F., Cao, J., Cao, J., Xiao, Z., Yang, Z., Yang, Z., Duan, J., & Xu, F. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1485885 · Cited by 13
“In this research, we noted that CUMS promoted tumor growth in a successfully established comorbidity of ovarian cancer and depression in vivo mouse model, consistent with previous studies (Thaker et al., 2006), and provided a novel therapeutic target.”
Autonomic modulation of the immune response and implications for CNS malignancies
Wachsmuth, L. P., Srinivasan, E. S., Puviindran, B. J., Haskell-Mendoza, A. P., DeSpenza, T., & Fecci, P. E. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-00957-y · Cited by 11
“A number of in vivo studies using chronic stress models have demonstrated that both chronic stress and ADRB agonism promote tumor growth, invasion, and vascularity in melanoma 163 , ovarian 164 , pancreatic 165 , and colorectal cancers 166 .”
The Relationship Between Psychosocial Stressors and Breast Cancer Biology
Melhem‐Bertrandt, A., & Conzen, S. D. (2010) · Current Breast Cancer Reports · doi:10.1007/s12609-010-0021-5 · Cited by 11
“It should also be mentioned that although there have not been specific animal studies examining the role of the SNS response to stress and breast tumor growth, downstream effectors of the SNS (catecholamines) have been shown to play an important role in mediating the effects of stress on ovarian carcinoma growth [ 47…”
BackgroundDlamini, Z., Mathabe, K., Padayachy, L. C., Marima, R. M., Evangelou, G., Syrigos, K. N., Bianchi, A., Lolas, G., & Hull, R. (2021) · Cancers · doi:10.3390/cancers13092138 · Cited by 11
Jeong, J.-H., Park, H.-J., Chi, G., Choi, Y. H., & Park, S. (2023) · Molecules · doi:10.3390/molecules28083414 · Cited by 11
Multiple types of distress are prospectively associated with increased risk of ovarian cancer
Roberts, A. L., Ratanatharathorn, A. D., Chibnik, L. B., Kubzansky, L. D., & Tworoger, S. S. (2023) · Cancer Medicine · doi:10.1002/cam4.6125 · Cited by 12
“Social isolation was assessed using the Berkman– Syme Social Network Index (SNI), which assessed four types of social connections: (1) marital status (married or unmarried), (2) close friends and relatives, (3) religious participation, and (4) nonreligious group participation.”
Methodβ2‐adrenergic receptor expression in patients receiving bevacizumab therapy for metastatic melanoma
Schuster, C., Akslen, L. A., & Straume, O. (2023) · Cancer Medicine · doi:10.1002/cam4.6424 · Cited by 12
Role of G protein-coupled receptor kinase 2 in tumoral angiogenesis
Rivas, V., Nogués, L., Reglero, C., Mayor, F., & Penela, P. (2014) · Molecular & Cellular Oncology · doi:10.4161/23723548.2014.969166 · Cited by 12
“Cumulative evidence indicates that chronic neurosympathetic activity affects the activity of the immune system,(45) as well as the malignant growth and dissemination of tumor cells, through direct stimulation of b2-adrenergic receptors (ARs).(45,46) Several processes appear to underlie the influence of bARs on tumor p…”
BackgroundBernier, M., Paul, R. K., Dossou, K. S. S., Wnorowski, A., Ramamoorthy, A., Pâris, A., Moaddel, R., Cloix, J., & Wainer, I. W. (2013) · Pharmacology Research & Perspectives · doi:10.1002/prp2.10 · Cited by 11
“The b2-adrenergic receptor (b2-AR) has a key role in angiogenesis (Ciccarelli et al. 2011) and promotion of malignant tumor growth (Thaker et al. 2006; Wong et al. 2007), and b2-AR overexpression is frequently found in biopsies from human glioblastoma and brain tumorassociated vasculature, which is…”
BackgroundRobb, S. W., Benson, K., Middleton, L., Meyers, C., & Hébert, J. R. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0545-3 · Cited by 12
“and cancer progression in laboratory studies [12,13].”
Khalili, A., Hassan, Z. M., Shahabi, S., Pourfathollah, A. A., Ostad, S. N., Noori, S., Mahdavi, M., Haybar, H., & Langroudi, L. (2013) · PubMed · doi:10.22034/iji.2013.16811 · Cited by 11
Social support and ovarian cancer incidence – A Swedish prospective population-based study
Idahl, A., Hermansson, A., & Lalos, A. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.03.042 · Cited by 11
Böhm, E. W., Stoffelns, B. M., & Gericke, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054698 · Cited by 11
Fundamental Principles of Cancer Biology: Does It Have Relevance to the Perioperative Period?
Li, J., Nick, A. M., & Sood, A. K. (2015) · Current anesthesiology reports · doi:10.1007/s40140-015-0122-9 · Cited by 14
“Many different malignancies express receptors for catecholamines [62] and prostaglandins [63] exerting a direct tumoral effect, which includes promotion of tumor cell proliferation [64], adhesion [65], migration [66] and invasion [64], resistance to apoptosis and anoikis [67, 68], as well as secretion of proangiogenic…”
BackgroundSelf-citationPark, M. J., Guest, C. B., Barnes, M. B., Martin, J. G., Ahmad, U., York, J. M., & Freund, G. G. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.08.005 · Cited by 13
“To determine if catecholamine dependent social withdrawal was mediated by the beta-2 adrenergic receptor, beta-2 agonism was performed using the beta-2 agonist terbutaline (Podojil et al., 2004; Ito et al., 2006; Thaker et al., 2006).”
MethodDendrimer-Based RNA Interference Delivery for Cancer Therapy
Xu, L., Yeudall, W. A., & Yang, H. (2013) · ACS symposium series · doi:10.1021/bk-2013-1135.ch012 · Cited by 11
The Clinical Relevance of Beta Blockers in Ovarian Carcinoma
Hefner, J., & Csef, H. (2016) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-0042-115016 · Cited by 12
“This is applicable to both the direct effects of catecholamines on tumour cells (anoikis, cell migration and invasion) [18 – 22] and indirect effects on the tumour microenvironment (inflammation, angiogenesis) [23 – 26] ( l " Table 1 ).”
Yoshizawa, K., Tabuchi, M., Ukai, S., Suzuki, H., Kawano, Y., & Takasawa, R. (2020) · Anticancer Research · doi:10.21873/anticanres.14309 · Cited by 12
Role of Neurotransmitters and Neuropeptides in Breast Cancer Metastasis
Pouya, F. D., Rasmi, Y., & Asl, E. R. (2020) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747820020142 · Cited by 11
Mendes, A. D., Freitas, A. R., Vicente, R. S., Ferreira, R., Martins, T., Ramos, M. J., Baptista, C., Silva, B. M., Margarido, I., Vitorino, M. M., et al. (2024) · Cureus · doi:10.7759/cureus.52194 · Cited by 12
“These genes can promote inflammation, cellular invasion, and angiogenesis [6,15-17].”
BackgroundChronic stress promotes gastric cancer progression via the adrenoceptor beta 2/PlexinA1 pathway
Lu, Y., Cheng, D., Pang, J., Peng, Y., Jin, S., Zhang, X., Li, Y., & Zuo, Y. (2024) · Cell Stress and Chaperones · doi:10.1016/j.cstres.2024.02.001 · Cited by 11
“19 Previous studies have shown that ADRB2 is involved in hepatocellular carcinoma, 20 prostate cancer, 21 and pancreatic cancer.”
BackgroundSelf-citationWei, J., Liu, H., Li, Y., Zhao, D., Wang, B., Wang, H., Wang, L., Wang, K., Yue, J., Zhang, H., et al. (2024) · Journal of Pineal Research · doi:10.1111/jpi.70002 · Cited by 10
Self-citationAssociation of neighborhood social vulnerability with ovarian cancer survival
Borho, L., Elishaev, E., Bao, R., O'Brien, E. C., Dinkins, K. G., Berger, J. L., Boisen, M. M., Comerci, J. T., Courtney-Brooks, M. B., Edwards, R. P., et al. (2024) · Gynecologic Oncology · doi:10.1016/j.ygyno.2024.10.030 · Cited by 10
Allostatic load and cancer risk, progression, and mortality in epidemiologic studies
Ishibe, N., Ellison, G. L., Rao, D., & Lam, T. K. (2025) · American Journal of Epidemiology · doi:10.1093/aje/kwaf038 · Cited by 11
Molecular mechanisms and clinical value of the correlation between depression and cancer
Chen, Y., Lu, Y.-F., Chen, S., Liu, P., He, J., Jiang, L., & Zhang, J. (2025) · Medical Oncology · doi:10.1007/s12032-025-02763-9 · Cited by 14
“After nude mice with human ovarian cancer cells experienced stress, VEGF expression was increased in tumors via β 2-AR-cyclic AMP-protein kinase A signaling, thereby promoting the vascularization and growth of tumor [107].”
Tumor Innervation: From Bystander to Emerging Therapeutic Target for Cancer
Ji, Z. Z., Chan, M. K., Tang, P. C., Ng, C. S. H., Li, C., Zhang, D., Nikolic‐Paterson, D. J., To, K., Jiang, X., & Tang, P. M.-K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189257 · Cited by 13
“Chronic stress and biobehavioral factors such as depression and low social support are associated with elevated intratumoral NE levels, which correlate with accelerated tumor growth and poor prognosis [117,170,171].”
Divyashree, S., Sarjan, H. N., & Yajurvedi, H. N. (2015) · Canadian Journal of Zoology · doi:10.1139/cjz-2015-0150 · Cited by 11
Renna, M. E., Shrout, M. R., Madison, A. A., Jaremka, L. M., Alfano, C. M., Povoski, S. P., Agnese, D. M., Carson, W. E., & Kiecolt‐Glaser, J. K. (2021) · Journal of Cancer Survivorship · doi:10.1007/s11764-020-00977-6 · Cited by 11
Zhang, J. F., Sheng, H., Chen, J., Mohammadpour, H., Ma, S. J., Farrugia, M. K., Gandhi, S., Bouchard, E., Singh, A. K., Repasky, E. A., et al. (2022) · Cancers · doi:10.3390/cancers14102541 · Cited by 10
“Elevated levels of catecholamines also activate β2-adrenergic receptor (ADRβ2)-mediated cyclic adenosine monophosphate (cAMP) signaling pathways in tumor cells [3], which subsequently produce changes in the extracellular architecture that allow for further tissue invasion and metastasis by cancer cells.”
BackgroundThe effect of aerobic exercise on tumour blood delivery: a systematic review and meta-analysis
Seet-Lee, C., Yee, J., Morahan, H., Ross, L. S., & Edwards, K. M. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-022-07132-0 · Cited by 21
“Additionally, the impact of stress on animals, such as stimulation for forced aerobic exercise, is particularly significant in cancer outcomes, whereby it has been postulated that the immune response plays a part in the development of tumour vasculature to promote microvessel density and tumour growth in mice [44, 45].”
BackgroundChen, A., Kelley, L. D. S., & Janušonis, S. (2012) · Brain Research · doi:10.1016/j.brainres.2012.04.019 · Cited by 12
Mahanti, S., Majhi, A., Chongdar, S., Kundu, K., Dutta, K., Basu, A., & Bishayi, B. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.11.001 · Cited by 10
“Two-hour restraint time was chosen as this had been shown to be sufficient to result in immunomodulation (Thaker et al., 2006).”
Novel roles of perivascular nerves on neovascularization
Lei, H. C., Zou, Z., Tian, H., Zhang, Y., Song, C., Zhou, H., & Liu, L. (2014) · Neurological Sciences · doi:10.1007/s10072-014-2016-x · Cited by 12
Pathological hypertrophy reverses β 2 -adrenergic receptor-induced angiogenesis in mouse heart
Xu, Q., Jennings, N. L., Sim, K., Chang, L., Gao, X., Kiriazis, H., Lee, Y. Y., Nguyen, M., Woodcock, E. A., Zhang, Y., et al. (2015) · Physiological Reports · doi:10.14814/phy2.12340 · Cited by 10
“A paracrine regulation of angiogenesis by b2AR has previously been reported in tumor, (Thaker et al. 2006; Wu et al. 2007; Perez-Sayans et al. 2010; Zhang et al. 2010; Pasquier et al. 2013) or the retina, (Martini et al. 2011) where activation of b2AR mediates release of angiogenic factors XZC from…”
BackgroundInfluentialSelf-citationRelationship status and other demographic influences on survival in patients with ovarian cancer
Gardner, A. B., Sanders, B. E., Mann, A. K., Liao, C.-I., Eskander, R. N., Kapp, D. S., & Chan, J. K. (2020) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2020-001512 · Cited by 10
Intensity of metastasis screening and survival outcomes in patients with breast cancer
Cheun, J.-H., Jung, J. G., Lee, E.-S., Rhu, J., Lee, H., Lee, K.-H., Kim, T., Han, W., Im, S., Noh, D., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-82485-w · Cited by 11
Self-citationThe Adrenergic Nerve Network in Cancer
Magnon, C. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-73119-9_15 · Cited by 10
Zenga, J., Awan, M. J., Frei, A. C., Petrie, E., Sharma, G. P., Shreenivas, A. V., Shukla, M., & Himburg, H. A. (2022) · Head & Neck · doi:10.1002/hed.27028 · Cited by 10
Arese, M., Bussolino, F., Pergolizzi, M., & Bizzozero, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314695 · Cited by 11
Kido, A., Yoshitani, K., Shimizu, T., Akahane, M., Fujii, H., Tsukamoto, S., Kondo, Y., Honoki, K., Imano, M., & Tanaka, Y. (2012) · Oncology Letters · doi:10.3892/ol.2012.813 · Cited by 10
“In addition, β2AR activation leads to the upregulation of hypoxia-inducible factor-1α (HIF-1α) via Akt and ERK1/2 signaling (8), that may be a mechanism by which β2AR signaling accelerates tumor growth in several types of cancer (9-13).”
BackgroundCommutative regulation between endothelial NO synthase and insulin receptor substrate 2 by microRNAs
Sun, X., Lv, H., Zhao, P., He, J., Cui, Q., Wei, M., Feng, S., & Zhu, Y. (2018) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjy055 · Cited by 11
Zhang, J., Zhao, Y., Sun, N., Song, M., Chen, Y., Li, L., Cui, H., Yang, H., Wang, C., Zhang, H., et al. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c07550 · Cited by 10
Komine, C., Sohda, M., Yokobori, T., Shioi, I., Ozawa, N., Shibasaki, Y., Nakazawa, N., Osone, K., Shiraishi, T., Okada, T., et al. (2024) · Annals of Surgical Oncology · doi:10.1245/s10434-024-16195-8 · Cited by 10
Wang, Z., Chen, X., Wang, Q., & Wang, Y. (2025) · Discover Oncology · doi:10.1007/s12672-025-02067-4 · Cited by 10
Rivera-López, Y. A., Torres-Rosado, A. P., Casiano-Martínez, J. A., Meléndez-Rodríguez, L. L., Imad-Hamad, R., Hernández-Carrasquillo, S. M., Rivera-Pérez, L. M., Ortiz-León, M., Torres-Rodríguez, O. I., Aquino-Acevedo, A. N., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1593299 · Cited by 9
Hassan, M. Z. O., Tawakol, A. A., Wang, Y., Alvi, R. M., Awadalla, M., Jones‐O’Connor, M., Bakar, R. B., Banerji, D., Rokicki, A., Zhang, L., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0279235 · Cited by 11
Prostate Cancer, Race, and Health Disparity: What We Know
Roach, M., Coleman, P. W., & Kittles, R. A. (2023) · The Cancer Journal · doi:10.1097/ppo.0000000000000688 · Cited by 9
Ogilvie, L. M., Coyle‐Asbil, B., Brunt, K. R., Petrik, J., & Simpson, J. A. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00795.2023 · Cited by 9
Unraveling the peripheral nervous System's role in tumor: A Double-edged Sword
Wang, Y.-H., Xuan, Y., Liu, C., Wang, X., & Yu, K. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217451 · Cited by 9
Fang, C. Y., Egleston, B. L., Ridge, J. A., Lango, M. N., Bovbjerg, D. H., Studts, J. L., Burtness, B. A., Einarson, M. B., & Klein–Szanto, A. J. (2013) · Head & Neck · doi:10.1002/hed.23421 · Cited by 11
The role of neural-related factors in the metastasis of the gastrointestinal cancer
Zeng, H., Xu, X., Xu, B., & Song, Q. (2013) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.122505 · Cited by 11
Light pollution: hidden perils in light and links to cancer
Rajput, S., Naithani, M., Meena, K., & Rana, S. V. (2021) · Sleep and Vigilance · doi:10.1007/s41782-020-00123-3 · Cited by 11
Harðardóttir, H., Aspelund, T., Zhu, J., Fall, K., Hauksdóttir, A., Fang, F., Lu, D., Janson, C., Jónsson, S., Valdimarsdottir, H. B., et al. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-021-06138-4 · Cited by 11
Taylor, M. R., Knight, J. M., & Rosenberg, A. R. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100321 · Cited by 9
Cancer as a tool for preclinical psychoneuroimmunology
Borniger, J. C. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100351 · Cited by 13
Cancer Therapy and Dendritic Cell Immunomodulation
Shurin, G. V., Amina, N., & Shurin, M. R. (2009) · Springer eBooks · doi:10.1007/978-0-387-88611-4_14 · Cited by 9
β-Adrenergic Receptors : New Target in Breast Cancer
Wang, T., Li, Y., Lu, H.-L., Meng, Q.-W., Cai, L., & Chen, X.-S. (2016) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.18.8031 · Cited by 11
“Norepinephrine induces VEGF expression and angiogenesis by a hypoxiainducible factor-1 α protein-dependent mechanism.”
BackgroundInfluentialSelf-citationIntegrative oncology: the last ten years--a personal retrospectve.
Boyd, D. B. (2007) · PubMed · Cited by 9
Crosstalk between signaling pathways and DNA damage response
Wang, K., Li, L., Zhang, Y., & Gao, D. (2019) · Genome Instability & Disease · doi:10.1007/s42764-019-00005-7 · Cited by 10
An integrative review of nonobvious puzzles of cellular and molecular cardiooncology
Uruski, P., Matuszewska, J., Leśniewska, A., Rychlewski, D., Niklas, A. A., Mikuła‐Pietrasik, J., Tykarski, A., & Książek, K. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00451-y · Cited by 9
“Experimental studies showed that increased sympathetic nervous system activity may promote cancer development [499].”
BackgroundLong, Y., Zhang, W., Zheng, M., Xie, Q., Liu, H., Hu, X., Zhang, X., Huang, W., Gao, X., Jiang, C., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.944354 · Cited by 9
“Meanwhile, catecholamines may promote breast or ovarian tissue hyperplasia and canceration in vivo (24).”
BackgroundAssociation of allostatic load with overall survival in epithelial ovarian cancer
Borho, L., Bao, R., Elishaev, E., Dinkins, K. G., O'Brien, E., Berger, J., Boisen, M. M., Comerci, J. T., Courtney-Brooks, M. B., Edwards, R. P., et al. (2024) · Gynecologic Oncology · doi:10.1016/j.ygyno.2024.05.031 · Cited by 9
Zhang, R., Wang, W., Li, A., Wang, H., Liu, X., Fan, F., Wang, Y., Zhang, H., Chang, J., Zhang, Y., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1497468 · Cited by 11
“The b 2 adrenergic receptor ( b 2AR) is a prototypical G protein-coupled receptor (GPCR) that can increase intracellular cyclic adenosine monophosphate (cAMP) levels and activate the protein kinase A (PKA) pathway (44).”
Self-citationArsalan, H. M., Mumtaz, H., & Laganà, A. S. (2025) · Advances in clinical chemistry · doi:10.1016/bs.acc.2025.01.004 · Cited by 11
Deciphering the Overlapping Immune Mechanism Between Depression and Breast Cancer
Ma, Y., Yu, M., Hou, Z., Yu, Y., Liu, J., & Wang, Z. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115229 · Cited by 9
Lam, T., Cardwell, B., Liu, B., Peng, C., Spark, M., Sursock, S., Nowell, C. J., Ellisdon, A. M., Chang, A., Keen, A. C., et al. (2025) · Science Signaling · doi:10.1126/scisignal.adq8279 · Cited by 8
Peripheral Nerves in Cancer: Regulatory Roles and Therapeutic Strategies
Fu, Y., Ge, Z., Cao, Q., Li, Z., Zhang, A., Zhu, H., & Teng, G. (2026) · MedComm · doi:10.1002/mco2.70594 · Cited by 10
What is Integrative Oncology and Can It Help My Patients?
Pineda, M. J., & Singh, D. K. (2012) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2012.03.001 · Cited by 10
A portable medical device for detecting diseases using Probabilistic Neural Network
Moradkhani, A. R., Broumandnia, A., & Mirabedini, S. J. (2021) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2021.103142 · Cited by 8
Using Free-Range Laboratory Mice to Explore Foraging, Lifestyle, and Diet Issues in Cancer
Makin, D. F., Agra, E., Prasad, M., Brown, J. S., Elkabets, M., Menezes, J. F. S., Sargunaraj, F., & Kotler, B. P. (2021) · Frontiers in Ecology and Evolution · doi:10.3389/fevo.2021.741389 · Cited by 9
Chronic Stress Does Not Influence the Survival of Mouse Models of Glioblastoma
Lopes, M., de Castro, J. V., Pojo, M., Gonçalves, C. S., Martins, E. P., Coimbra, B., Sotiropoulos, I., Sousa, N., Rodrigues, A. J., & Costa, B. M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.856210 · Cited by 8
“Since most studies associating chronic stress with cancer progression in animal models are based on the restraint stress paradigm with immunocompromised mice (1, 2, 5, 30), we used a similar approach.”
BackgroundMethodAxon guidance molecules in liver pathology: Journeys on a damaged passport
Chicherova, I., Hernandez, C. A., Mann, F., Zoulim, F., & Parent, R. (2023) · Liver International · doi:10.1111/liv.15662 · Cited by 9
The stress connection in cancer: the adrenergic fuelling of breast tumors
Albitre, Á., Reglero, C., González-Muñoz, T., & Penela, P. (2023) · Current Opinion in Physiology · doi:10.1016/j.cophys.2023.100720 · Cited by 9
Zhao, S., Xie, Y., Xu, D., Zheng, C., Chen, J., Zhao, N., Ji, Y., Wang, Q., Liu, Y., & Cheng, C. (2024) · Environmental Toxicology · doi:10.1002/tox.24210 · Cited by 9
“26 These effects are orchestrated through the activation of cancer cell β -AR, subsequently initiating downstream cellular cyclic AMP-protein kinase A signaling pathways.”
Background
Metadata
- Authors
- Thaker, P. H., Han, L. Y., Kamat, A. A., Arevalo, J. M., Takahashi, R., Lu, C., Jennings, N. B., Armaiz-Pena, G., Bankson, J. A., Ravoori, M., Merritt, W. M., Lin, Y. G., Mangala, L. S., Kim, T. J., Coleman, R. L., Landen, C. N., Li, Y., Felix, E., Sanguino, A. M., Newman, R. A., Lloyd, M., Gershenson, D. M., Kundra, V., Lopez-Berestein, G., Lutgendorf, S. K., Cole, S. W., & Sood, A. K.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of California, Los Angeles (US)
- University of Iowa (US)
- Corresponding author
- Sood, Anil K
- ORCID
- Venue
- Nature Medicine
- Published
- 2006-07-23
- Volume
- 12
- Issue
- 8
- Pages
- 939-944
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2151356556
- Cited by
- 1,320
- References
- 31
- Citations by year
- 2026: 69 · 2025: 83 · 2024: 100 · 2023: 88 · 2022: 71 · 2021: 82 · 2020: 90 · 2019: 66 · 2018: 64 · 2017: 55 · 2016: 70 · 2015: 74 · 2014: 59 · 2013: 72 · 2012: 63
- FWCI
- 23.64
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-11-19)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Johnson and Johnson
- National Cancer Institute (CA10929801, U01CA213759, CA-104825, CA 11079301, R01CA104825, P50CA083639)
- National Institute of Allergy and Infectious Diseases (AI 52737, R01AI052737)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Keywords
- chronic stress, ovarian carcinoma, tumor angiogenesis, tumor growth, beta2-adrenergic receptor, cAMP signaling, protein kinase A, catecholamines, vascular endothelial growth factor, matrix metalloproteinases, tumor invasion, orthotopic xenograft
- MeSH terms
- Animals, Carcinoma, Disease Models, Animal, Drug Combinations, Enzyme Inhibitors, Female, Humans, Isoproterenol, Mice, Nude, Neoplasm Transplantation, Neovascularization, Pathologic, Organ Size, Ovarian Neoplasms, Phthalazines, Pyridines, Radiography, Random Allocation, Stress, Psychological, Terbutaline, Transplantation, Heterologous, Vascular Endothelial Growth Factor A, Cell Line, Tumor, Tumor Burden, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.